Entecavir: Difference between revisions

Revision as of 16:32, 3 January 2014

entecavir
BARACLUDE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Entecavir (INN) (Template:PronEng) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.

US Brand Names

BARACLUDE^®

FDA Package Insert

Mechanism of Action

References

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{XXXXX}}
+{{Entecavir}}
 {{CMG}}
@@ Line 10: / Line 10: @@
 ==Category==
 Antiviral
 ==US Brand Names==
 BARACLUDE<sup>®</sup>
 ==FDA Package Insert==
-'''  [[XXXXX description|Description]]'''
+'''  [[Entecavir description|Description]]'''
-'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[Entecavir clinical pharmacology|Clinical Pharmacology]]'''
-'''| [[XXXXX microbiology|Microbiology]]'''
+'''| [[Entecavir microbiology|Microbiology]]'''
-'''| [[XXXXX indications and usage|Indications and Usage]]'''
+'''| [[Entecavir indications and usage|Indications and Usage]]'''
-'''| [[XXXXX contraindications|Contraindications]]'''
+'''| [[Entecavir contraindications|Contraindications]]'''
-'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
+'''| [[Entecavir warnings and precautions|Warnings and Precautions]]'''
-'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
+'''| [[Entecavir adverse reactions|Adverse Reactions]]'''
-'''| [[XXXXX drug interactions|Drug Interactions]]'''
+'''| [[Entecavir drug interactions|Drug Interactions]]'''
-'''| [[XXXXX overdosage|Overdosage]]'''
+'''| [[Entecavir overdosage|Overdosage]]'''
-'''| [[XXXXX clinical studies|Clinical Studies]]'''
+'''| [[Entecavir clinical studies|Clinical Studies]]'''
-'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
+'''| [[Entecavir dosage and administration|Dosage and Administration]]'''
-'''| [[XXXXX how supplied|How Supplied]]'''
+'''| [[Entecavir how supplied|How Supplied]]'''
-'''| [[XXXXX labels and packages|Labels and Packages]]'''
+'''| [[Entecavir labels and packages|Labels and Packages]]'''
 ==Mechanism of Action==
 ==References==